Free tool
FAERS Monitor: Duraclon
Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020615 or its brand name (Duraclon, Clonidine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
5,684
Serious
3,889
68% of reports
Hospitalization
1,617
Death reported
937
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- hypertension762
- headache711
- off label use658
- pain640
- fatigue634
- hypersensitivity549
- drug ineffective524
- nausea476
- infusion related reaction442
- hepatic enzyme increased436
- joint swelling426
- rash411
- dyspnoea387
- prescribed overdose374
- diarrhoea369
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 13 |
| 2007 | 11 |
| 2008 | 30 |
| 2009 | 16 |
| 2010 | 66 |
| 2011 | 115 |
| 2012 | 102 |
| 2013 | 67 |
| 2014 | 72 |
| 2015 | 110 |
| 2016 | 117 |
| 2017 | 244 |
| 2018 | 236 |
| 2019 | 222 |
| 2020 | 261 |
| 2021 | 329 |
| 2022 | 618 |
| 2023 | 649 |
| 2024 | 894 |
| 2025 | 895 |
| 2026 | 608 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,475 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| prescribed overdoseSignal | 374 | 72.9 | 66.0 | 25,965 |
| infusion related reactionSignal | 442 | 24.8 | 22.7 | 10,051 |
| hepatic enzyme increasedSignal | 436 | 23.8 | 21.8 | 9,475 |
| hypertensionSignal | 762 | 13.4 | 12.5 | 8,756 |
| joint swellingSignal | 426 | 13.1 | 12.0 | 4,760 |
| hypersensitivitySignal | 549 | 11.0 | 10.1 | 4,996 |
| headacheSignal | 711 | 4.2 | 3.9 | 1,781 |
| painSignal | 640 | 3.9 | 3.6 | 1,392 |
| rashSignal | 411 | 3.5 | 3.2 | 743 |
| fatigueSignal | 634 | 3.0 | 2.8 | 884 |
| off label useSignal | 658 | 2.8 | 2.6 | 781 |
| dyspnoeaSignal | 387 | 2.5 | 2.3 | 366 |
| nauseaSignal | 476 | 2.2 | 2.0 | 333 |
| diarrhoeaSignal | 369 | 2.1 | 1.9 | 223 |
| drug ineffective | 524 | 1.5 | 1.4 | 84 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.